Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer
Takumi Sakurada(Tokushima University Hospital), Keisuke Ishizawa(Tokushima University Hospital), Yasuhiko Nishioka(Tokushima University), Hiroaki Yanagawa(Tokushima University Hospital), Naoto Okada(Yamaguchi University Hospital), Hirotaka Nishisako(Tokushima University Hospital), Yuya Horinouchi(Tokushima University), Soichiro Tajima(Kyushu University Hospital), Toshimi Nakamura(Tokushima University Hospital), Kazuhiko Teraoka(Tokushima University Hospital), Kazuyoshi Kawazoe(SHOWA Medical University), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Kazuo Minakuchi(Osaka City University)
Cited by 47
Related Papers
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134